Cardinal Health vs Henry Schein
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Cardinal Health and Henry Schein side by side, using each one’s latest annual report. Here is what stands out:
- Cardinal Health is the larger business, with $254.2B of revenue in fiscal 2026 against $13.2B for Henry Schein, about 19 times as much.
- Cardinal Health grew revenue faster (14.2%, against 4.0%).
- Henry Schein kept more of each dollar of sales as operating profit (5.0% operating margin, against 1.0%).
- Henry Schein turned more of its sales into free cash flow (4.4% FCF margin, against 1.8%).
Who comes out ahead
Of the 9 measures where higher (or lower) is clearly better, how many each company leads.
Cardinal Health
CAH
3/9
Revenue growth5-year growthNet debt / EBITDA
Henry Schein
HSIC
5/9
Gross marginOperating marginNet marginFCF marginShare count change
Side by side
Best in the row
| Latest fiscal year | CAH FY26 | HSIC FY25 |
|---|---|---|
| Size | ||
| Market cap | $59.1B | $9.7B |
| Revenue | $254.2B | $13.2B |
| Free cash flow | $4.5B | $573M |
| Net income | $1.7B | $398M |
| Growth | ||
| Revenue growth | 14.2% | 4.0% |
| 5-year growth | 9.4% | 5.4% |
| Share count change | −2.1% | −4.7% |
| Profitability | ||
| Gross margin | 3.8% | 31.1% |
| Operating margin | 1.0% | 5.0% |
| Net margin | 0.7% | 3.0% |
| FCF margin | 1.8% | 4.4% |
| Return on capital | — | 7.5% |
| Return on equity | — | 12.0% |
| Balance sheet | ||
| Net debt | $4.0B | $3.0B |
| Net debt / EBITDA | 1.1x | 3.1x |
| Dividends and buybacks | $1.8B | $850M |
| Valuation & quality | ||
| P/E | — | 24.8x |
| Piotroski F-score | 6 | 6 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.